Cargando…
New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers
Cisplatin is the first and most widely used platinum-based chemotherapy drug and is the cornerstone agent in treating a broad spectrum of cancers. However, its clinical application is often limited by severe toxic side effects and drug resistance. Based on the discovered dissociative electron transf...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804005/ https://www.ncbi.nlm.nih.gov/pubmed/33436996 http://dx.doi.org/10.1038/s41598-020-80876-z |